Jazz Pharmaceuticals Eulerpool News

Jazz Pharmaceuticals Eulerpool News

Jazz Pharmaceuticals Stock News

Jazz Pharmaceuticals is being monitored by journalists and investors worldwide. We gather the latest Jazz Pharmaceuticals news here.

• October 4 ·

  Benzinga
  Assessing Jazz Pharmaceuticals: Insights From 12 Financial Analysts
• October 4 ·

  GuruFocus
  Jazz Pharmaceuticals: Unveiling Growth Potential From Non-Small Cell Lung Cancer Market
• September 27 ·

  SeekingAlpha
  Zymeworks Approaching A Moment Of Truth With Zanidatamab
• September 19 ·

  SeekingAlpha
  Jazz Pharmaceuticals: Zanidatamab Is A Potential Growth Catalyst
• September 18 ·

  Yahoo
  Jazz Pharmaceuticals' (NASDAQ:JAZZ) earnings have declined over five years, contributing to shareholders 16% loss
• September 18 ·

  TipRanks
  Jazz Pharmaceuticals (JAZZ) Gets a Buy from Truist Financial
• September 16 ·

  Yahoo
  Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024
• September 16 ·

  Thefly.com
  Jazz Pharmaceuticals presents updated Phase 2 data for zanidatamab
• September 15 ·

  Seeking Alpha
  Stock moves reflect downgrade for US economic growth outlook - Goldman
• September 12 ·

  Thefly.com
  Truist healthcare analyst holds an analyst/industry conference call